Rockwell Medical, Inc. (RMTI)

Evaluation: Based on all recent filings, financial statements, and news.

See full evaluation
Company performance

Current Price

as of Jan 07, 2025

$2.23

P/E Ratio

N/A

Market Cap

$72.07M

Jan 22, 2024Feb 26, 2024Apr 1, 2024May 2, 2024Jun 5, 2024Jul 9, 2024Aug 8, 2024Sep 12, 2024Oct 17, 2024Nov 21, 2024Jan 7, 2025$0.00$10.00
  • RMTI
Description

Rockwell Medical, Inc. is a biopharmaceutical company, which engages in the development of treatment for anemia, kidney disease, iron deficiency, and hemodialysis. Its products include Triferic, CitraPure, RenalPure and SteriLyte. The company was founded by Robert L. Chioini in 1996 and is headquartered in Wixom, MI.

Metrics

Overview

  • HQWixom, MI
  • SectorHealth Technology
  • IndustryMedical Specialties
  • TickerRMTI
  • Price$2.23-1.11%

Trading Information

  • Market cap$72.07M
  • Float86.74%
  • Average Daily Volume (1m)491,367
  • Average Daily Volume (3m)724,058
  • EPS-$0.06

Company

  • Revenue$98.92M
  • Rev growth (1yr)19.12%
  • Net income$1.43M
  • Gross margin22.03%
  • EBITDA margin8.75%
  • EBITDA$2.48M
  • EV$124.61M
  • EV/Revenue1.26
  • P/EN/A
  • P/S0.73
  • P/B2.47
Documents